Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Plans laid for trials of emergency care medicines to treat children

Marmion/iStockphoto

Sick child

In emergencies, parents’ prior consent for treatment is usually hard to obtain

Research into emergency care for children will no longer require prior authorisation if legislative amendments proposed by the Medicines and Healthcare products Regulatory Agency are adopted.

The MHRA says that the current system prevents trials of emergency-care medicines for children taking place in the UK because prior consent cannot usually be obtained.

Its proposed amendments, which have opened for consultation, suggest that, in certain emergencies, there should be an exception to the general rule that informed consent must be obtained from a child’s parent or legal representative before participation in trials of medicines.

An ethics committee would have to approve the detailed circumstances in which the exception would be used and consent would have to be obtained as soon as reasonably practicable after participation starts. The MHRA envisages that, in practice, the change would mirror an amendment made last year in relation to incapacitated adults.

The change is one of three suggested changes to the Medicines for Human Use (Clinical Trials) Regulations 2004. The other two relate to delegating some of the Gene Therapy Advisory Committee’s functions and amending the regulations for appointing members to UK ethics committees. The proposals are available online.

The deadline for comments is 7 December 2007.

Citation: The Pharmaceutical Journal URI: 10004848

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 1 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £138.50Buy now
  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 2 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £262.50Buy now
  • Patient Care in Community Practice

    Patient Care in Community Practice

    Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.

    £22.00Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Strategic Medicines Management

    Strategic Medicines Management

    A practical guide to influencing the availability of medicines, and policies of their use. Focuses on the strategic elements of medicines management.

    £33.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.